Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Current Liabilities

The Current Liabilities of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Oct 19, 2026 is 1.64 B CNY. In the previous year, Current Liabilities was 772.20 M CNY — a change of 112.00% (higher).

Current Liabilities

1.64 BCNY

YoY

112.00%

Last updated:

Current Liabilities of Tibet Rhodiola Pharmaceutical Holding is 2025 1.64 B CNY. Current Liabilities of Tibet Rhodiola Pharmaceutical Holding was 2024 772.20 M CNY. It decreases by 112.00% higher compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
263.95 M CNY
Jan 1, 2019
322.06 M CNY
Jan 1, 2020
344.78 M CNY
Jan 1, 2021
710.23 M CNY
Jan 1, 2022
1.04 B CNY
Jan 1, 2023
1.23 B CNY
Jan 1, 2024
772.20 M CNY
Jan 1, 2025
1.64 B CNY
The Tibet Rhodiola Pharmaceutical Holding Current Liabilities history
YEARCurrent LiabilitiesYoY
1.64 BCNY+112.00%
772.20 MCNY-37.39%
1.23 BCNY+18.98%
1.04 BCNY+45.94%
710.23 MCNY+106.00%
344.78 MCNY+7.05%
322.06 MCNY+22.02%
263.95 MCNY+2.18%
258.32 MCNY-83.30%
1.55 BCNY+586.00%
225.43 MCNY-63.65%
620.07 MCNY-39.13%
1.02 BCNY+117.58%
468.18 MCNY+11.49%
419.93 MCNY+19.66%
350.94 MCNY-2.93%
361.54 MCNY-32.78%
537.89 MCNY+1.34%
530.76 MCNY+6.31%
499.24 MCNY-23.91%
656.13 MCNY+15.25%
569.32 MCNY-7.75%
617.14 MCNY+5.48%
585.07 MCNY+74.70%
334.91 MCNY+133.85%
143.21 MCNY+92.11%
74.55 MCNY+11.46%
66.89 MCNY+706.31%
8.30 MCNY-69.27%
26.99 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co, listed on the Shanghai Stock Exchange under ticker 600211.SS, operates as a pharmaceutical company based in Lhasa, China. The company's ISIN is CNE000000ZW7. Founded through an IPO on July 21, 1999, it specializes in the manufacture and wholesale of pharmaceutical products. Its headquarters are located in Lhasa, Xizang, and it employs 615 full-time staff. The firm distributes proprietary drug products and processes pharmaceuticals, conducting business primarily across South China, North China, East China, Central China, and overseas markets. The company's website is http://www.xzyy.cn. It does not provide details on specific products, acquisitions, or financial figures beyond the IPO date and employee count. The company focuses on pharmaceutical manufacturing and distribution within its operational regions, with no additional information provided on its product lines or market share. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Current Liabilities of Tibet Rhodiola Pharmaceutical Holding is 1.64 B CNY in 2025.

Current Liabilities of Tibet Rhodiola Pharmaceutical Holding changed from 772.20 M CNY to 1.64 B CNY, representing a 112.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Tibet Rhodiola Pharmaceutical Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Tibet Rhodiola Pharmaceutical Holding

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding